Skip to content

Clinical trials

Phase 3 Uveitis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis Phase: Phase 3 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20103
20111
20122
20141
20151
20171
20192
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated6
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
JHSPH Center for Clinical Trials3
Lux Biosciences, Inc.3
Novartis Pharmaceuticals3
XOMA (US) LLC2
Eli Lilly and Company1
Institut de Recherches Internationales Servier1
Priovant Therapeutics, Inc.1
Santen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis15
Uveitis, Intermediate9
Uveitis, Posterior9
Panuveitis8
Macular Edema2
Cardiovascular Diseases1
Dermatitis1
Inflammation1
Myocardial Infarction1
Psoriasis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.